Jiangxi Fuyang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") announced on May 19, 2026, regarding the specific shareholder's share reduction plan (Announcement No.: 2026-057), that a total of 13,216,446 shares were reduced, accounting for 2.45% of the company's total shares. The share price during the reduction was not less than 690 RMB per share. The total number of shares held by the specific shareholder after the reduction does not exceed 10,772,900 shares (accounting for 2% of the company's total shares).
The company recently received a report from Mr. Wang Wenjun regarding the completion of the share reduction plan, which confirms that the actual reduction of shares was as follows: